Cost-effectiveness studies of HPV self-sampling: A systematic review

C Malone, RV Barnabas, DSM Buist, JA Tiro… - Preventive …, 2020 - Elsevier
Abstract HPV self-sampling (HPV-SS) can increase cervical cancer screening participation
by addressing barriers in high-and low-and middle-income settings. Successful …

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United …

E Meites, TJ Wilkin, LE Markowitz - Human Vaccines & …, 2022 - Taylor & Francis
Gay, bisexual, and other men who have sex with men (MSM) and transgender women,
particularly those who are living with HIV, are disproportionately affected by human …

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

K Canfell, JJ Kim, M Brisson, A Keane, KT Simms… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

KT Simms, A Keane, DTN Nguyen, M Caruana… - Nature Medicine, 2023 - nature.com
Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - thelancet.com
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …

Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis

Z Zou, CK Fairley, JJ Ong, J Hocking… - The Lancet Global …, 2020 - thelancet.com
Background Coinciding with the release of the first Chinese domestic human papillomavirus
(HPV) vaccine Cecolin in 2019, and the substantial advancements in cervical cancer …

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis

É Bénard, M Drolet, JF Laprise, G Gingras… - The Lancet Public …, 2023 - thelancet.com
Background Given the accumulating evidence that one-dose vaccination could provide high
and sustained protection against human papillomavirus (HPV) infection and related …

Projected time to elimination of cervical cancer in the USA: a comparative modelling study

EA Burger, MA Smith, J Killen, S Sy… - The Lancet Public …, 2020 - thelancet.com
Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV

MT Hall, KT Simms, JM Murray, A Keane… - Nature Medicine, 2023 - nature.com
To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …